This page collects WhisperX intelligence signals tagged #neuroscience. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Soleno Therapeutics stock is rallying sharply following a report that the company is in talks to be acquired by Neurocrine Biosciences for approximately $2.5 billion. The potential deal, which would represent a significant premium, has sent Soleno shares soaring as investors react to the prospect of a major consolidati...
Neurocrine Biosciences is making a major strategic move, acquiring Soleno Therapeutics in an all-cash transaction valued at approximately $2.6 billion. The deal, priced at $53 per share, represents a significant premium and immediately shifts the competitive landscape for rare disease treatments. This acquisition is no...
A major scientific review has delivered a devastating blow to the dominant theory of Alzheimer's disease treatment, concluding that drugs designed to clear amyloid plaques from the brain do not improve cognitive function or slow its decline. This finding directly challenges the foundational 'amyloid hypothesis' that ha...
Une simple mesure des mouvements oculaires pourrait révolutionner le diagnostic neurologique. La start-up NeuroClues affirme que chaque mouvement des yeux mobilise près de 60% du cerveau, faisant de cette activité un indicateur précieux de son fonctionnement. L'ambition de l'entreprise est claire : fournir aux neurolog...
A new biotech startup is betting that the next wave of treatments for complex brain disorders will come from Asia. Tortugas Neuroscience launched with $106 million in funding and a pipeline built on drugs licensed from major Chinese and Japanese pharmaceutical firms, signaling a strategic shift in sourcing neurological...